FATE SBC to Revenue
Fate Therapeutics Inc · SBC to Revenue
FATE SBC to Revenue
Latest reported168.97%period ending
FATE Quarterly SBC/Revenue (7.95% → 168.97%)
Latest values, visible window
High-resolution chart · PNG
FATE sbc to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SBC to Revenue |
|---|---|
| 168.9721% | |
| 302.4634% | |
| 403.7984% | |
| 279.2074% | |
| 375.1442% | |
| 453.1001% | |
| 490.3226% | |
| 382.7261% | |
| 142.2032% | |
| 570.4416% | |
| 0% | |
| 519.7531% | |
| 0% | |
| 18.6216% | |
| 0% | |
| 129.9513% | |
| 110.7445% | |
| 104.9799% | |
| 85.5% | |
| 95.1845% | |
| 98.822% | |
| 116.4602% | |
| 55.1145% | |
| 103.7708% | |
| 132.4062% | |
| 274.8708% | |
| 163.5617% | |
| 188.2668% | |
| 155.6976% | |
| 146.9605% | |
| 107.4052% | |
| 160.039% | |
| 144.5959% | |
| 134.6979% | |
| 87.147% | |
| 84.8928% | |
| 94.8343% | |
| 84.4206% | |
| 79.7468% | |
| 76.2183% | |
| 76.5336% | |
| 60.2874% | |
| 44.6097% | |
| 55.9454% | |
| 224.3161% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| -39.6498% | |
| 469.8565% | |
| 38.6207% | |
| 15.8898% | |
| 7.6205% | |
| 7.9545% |